| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 6.30e-05 | 9 | 27 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 6.30e-05 | 9 | 27 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.59e-04 | 14 | 27 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.76e-03 | 46 | 27 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 2.59e-03 | 56 | 27 | 2 | GO:0016763 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.75e-03 | 441 | 27 | 4 | GO:0016887 | |
| Domain | GPHH_dom | 3.90e-05 | 7 | 26 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 3.90e-05 | 7 | 26 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 3.90e-05 | 7 | 26 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 3.90e-05 | 7 | 26 | 2 | PF08763 | |
| Domain | GPHH | 3.90e-05 | 7 | 26 | 2 | PF16905 | |
| Domain | VDCCAlpha1 | 8.33e-05 | 10 | 26 | 2 | IPR002077 | |
| Domain | P-loop_NTPase | 1.20e-04 | 848 | 26 | 7 | IPR027417 | |
| Domain | - | 4.62e-04 | 746 | 26 | 6 | 3.40.50.300 | |
| Domain | Channel_four-helix_dom | 2.84e-03 | 57 | 26 | 2 | IPR027359 | |
| Domain | - | 2.84e-03 | 57 | 26 | 2 | 1.20.120.350 | |
| Domain | DEAD | 4.61e-03 | 73 | 26 | 2 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.61e-03 | 73 | 26 | 2 | IPR011545 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.03e-05 | 11 | 11 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.03e-05 | 11 | 11 | 2 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.03e-05 | 11 | 11 | 2 | MM14498 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.39e-04 | 23 | 11 | 2 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.64e-04 | 25 | 11 | 2 | M47948 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.29e-04 | 183 | 11 | 3 | M39588 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 5.87e-04 | 47 | 11 | 2 | M19708 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 6.91e-04 | 51 | 11 | 2 | M39457 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 7.19e-04 | 52 | 11 | 2 | M5785 | |
| Pathway | WP_MAPK_SIGNALING | 7.81e-04 | 246 | 11 | 3 | M39597 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 9.90e-04 | 267 | 11 | 3 | M10792 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.41e-03 | 73 | 11 | 2 | MM16641 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.00e-03 | 87 | 11 | 2 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.04e-03 | 88 | 11 | 2 | M41810 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.28e-03 | 93 | 11 | 2 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.33e-03 | 94 | 11 | 2 | M41818 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.58e-03 | 147 | 11 | 2 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.88e-03 | 151 | 11 | 2 | M39329 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 6.04e-03 | 153 | 11 | 2 | MM15844 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.83e-03 | 175 | 11 | 2 | MM15599 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.09e-03 | 178 | 11 | 2 | M2890 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 8.62e-03 | 184 | 11 | 2 | M41809 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.12e-02 | 211 | 11 | 2 | MM14502 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.22e-02 | 220 | 11 | 2 | M10320 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 5.80e-07 | 2 | 27 | 2 | 23426690 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15050706 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 38155373 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23376566 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.74e-06 | 3 | 27 | 2 | 24523520 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 1.74e-06 | 3 | 27 | 2 | 24394417 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 38996073 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.74e-06 | 3 | 27 | 2 | 29208674 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 1.74e-06 | 3 | 27 | 2 | 26507659 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 29466725 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 15728831 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 3.48e-06 | 4 | 27 | 2 | 32616470 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 26283199 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 3.48e-06 | 4 | 27 | 2 | 37141091 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 31253182 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 3.48e-06 | 4 | 27 | 2 | 15953418 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 3.48e-06 | 4 | 27 | 2 | 25483588 | |
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 8825650 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 11296258 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 16787652 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 15451373 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 8.69e-06 | 6 | 27 | 2 | 12827191 | |
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 10328888 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 8.69e-06 | 6 | 27 | 2 | 35324301 | |
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 9238069 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.22e-05 | 7 | 27 | 2 | 35176221 | |
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 16382099 | ||
| Pubmed | 3.81e-05 | 12 | 27 | 2 | 28949961 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.04e-05 | 1318 | 27 | 7 | 30463901 | |
| Pubmed | 5.25e-05 | 14 | 27 | 2 | 21228161 | ||
| Pubmed | 6.06e-05 | 15 | 27 | 2 | 24453333 | ||
| Pubmed | 6.06e-05 | 15 | 27 | 2 | 20188150 | ||
| Pubmed | 1.08e-04 | 119 | 27 | 3 | 24162774 | ||
| Pubmed | 1.32e-04 | 653 | 27 | 5 | 22586326 | ||
| Pubmed | 1.59e-04 | 24 | 27 | 2 | 22534482 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.65e-04 | 759 | 27 | 5 | 35915203 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 3.80e-04 | 37 | 27 | 2 | 25798587 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.01e-04 | 38 | 27 | 2 | 30786075 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 5.57e-04 | 497 | 27 | 4 | 36774506 | |
| Cytoband | Xp11.23 | 1.44e-03 | 95 | 27 | 2 | Xp11.23 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.35e-04 | 26 | 19 | 2 | 253 | |
| GeneFamily | AAA ATPases | 1.40e-03 | 53 | 19 | 2 | 413 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 3.11e-05 | 363 | 27 | 5 | M41103 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 5.03e-05 | 200 | 27 | 4 | M8618 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 5.03e-05 | 200 | 27 | 4 | M8620 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| Drug | AC 110 | 8.11e-06 | 4 | 27 | 2 | CID000022860 | |
| Drug | ELAN | 1.12e-05 | 37 | 27 | 3 | CID000009469 | |
| Drug | S 8510 | 1.35e-05 | 5 | 27 | 2 | CID005488383 | |
| Drug | alpha-sialylcholesterol | 2.03e-05 | 6 | 27 | 2 | CID000133976 | |
| Drug | 3,4-dihydroquinazoline | 2.03e-05 | 6 | 27 | 2 | CID000583065 | |
| Drug | APMPA | 2.83e-05 | 7 | 27 | 2 | CID000512300 | |
| Drug | 4-aminopiperidine | 7.40e-05 | 11 | 27 | 2 | CID000424361 | |
| Drug | leys | 7.40e-05 | 11 | 27 | 2 | CID000484683 | |
| Drug | AC1L2VU3 | 8.87e-05 | 12 | 27 | 2 | CID000129572 | |
| Drug | glufosinate | 9.87e-05 | 76 | 27 | 3 | CID000004794 | |
| Drug | AC1L1JG6 | 1.22e-04 | 14 | 27 | 2 | CID000005026 | |
| Drug | butamben | 1.41e-04 | 15 | 27 | 2 | CID000002482 | |
| Drug | pentasulfane | 1.61e-04 | 16 | 27 | 2 | CID000448216 | |
| Drug | Verapamil | 1.61e-04 | 16 | 27 | 2 | DB00661 | |
| Drug | pranidipine | 2.29e-04 | 19 | 27 | 2 | CID006436048 | |
| Drug | N6-Me-dAdo | 2.29e-04 | 19 | 27 | 2 | CID000168948 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.24e-06 | 3 | 26 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 4.47e-06 | 4 | 26 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.56e-05 | 7 | 26 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.08e-05 | 8 | 26 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 6.59e-04 | 43 | 26 | 2 | EFO_0004471, EFO_0006896 | |
| Disease | Parkinson disease | 2.75e-03 | 321 | 26 | 3 | MONDO_0005180 | |
| Disease | wellbeing measurement | 2.97e-03 | 692 | 26 | 4 | EFO_0007869 | |
| Disease | depressive symptom measurement | 6.07e-03 | 426 | 26 | 3 | EFO_0007006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KERRMRFYIRRMVKT | 471 | O00555 | |
| KRKTREQQMRHYMRF | 91 | Q9NWD9 | |
| RKEKMFRFFIRRMVK | 466 | Q00975 | |
| KEYMNRKMFGRDRII | 511 | Q7Z3E1 | |
| VRYGRRRMKLRDLME | 136 | Q9NU22 | |
| ENMDMYSRVKRRRKS | 226 | Q9ULI0 | |
| DMFEKGNYRRRRRMK | 136 | P58012 | |
| EKYRRTGNMARVMVR | 236 | Q969I3 | |
| RMRRKYFKNDMTTVR | 281 | Q4G148 | |
| LKMYNRKMRTRRELE | 51 | Q5T1S8 | |
| RKRDKVMFYGRKIMR | 51 | Q6ZV29 | |
| RMQARMRGFQARKRY | 361 | Q96JP2 | |
| RAVYRMSEMIFRRIK | 221 | Q6ZWL3 | |
| MAEANPRRGKMRFRR | 1 | P10911 | |
| QMRRMEVYNEFVRKR | 351 | Q13206 | |
| RRMESMRKEKRVYSR | 1121 | Q6ZRV2 | |
| RYKAMMEIRRLRGQL | 881 | Q8IY37 | |
| KMRVMGLRRQRNYAG | 461 | Q9BUJ2 | |
| KHREDMRGRRLKMYN | 261 | Q5VWQ0 | |
| GRERMDYMKRKSREY | 251 | Q3MII6 | |
| ELREQMSGYKRMRRQ | 456 | Q9H2K8 | |
| FMRKRRKGQDCRMEI | 91 | Q9UEE5 | |
| MKGRRRRRREYCKFA | 1 | Q9NS84 | |
| RGYMMSKQRERQLRR | 231 | Q86VR2 | |
| KSRMQMDGLRRRVYQ | 226 | Q8N413 | |
| MYAKRNKRRIMRIFS | 41 | Q96E16 | |
| RERKLIAKRRSYMMD | 751 | O00507 |